Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1

Citation
García-Domínguez, D. J., Hajji, N., López-Alemany, R., Sánchez-Molina, S., Figuerola-Bou, E., Morón Civanto, F. J., Rello-Varona, S., Andrés-León, E., Benito, A., Keun, H. C., Mora, J., Tirado, Ó. M., de Álava, E., & Hontecillas-Prieto, L. (2022). Selective histone methyltransferase G9a inhibition reduces metastatic development of Ewing sarcoma through the epigenetic regulation of NEU1. Oncogene, 41(18), 2638–2650. https://doi.org/10.1038/s41388-022-02279-w
DOI:
DOI: 10.1038/s41388-022-02279-w
Year of publication:
2022
Authors participating in BCBHub:
Eduardo Andres Leon